NEO-SYNEPHRINE 10 MG
PHENYLEPHRINE HYDROCHLORIDE : 10 MG · DIN 02241980 · PFIZER CANADA ULC
Health Canada status: CANCELLED POST MARKET
What is NEO-SYNEPHRINE?
NEO-SYNEPHRINE 10 MG contains PHENYLEPHRINE HYDROCHLORIDE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02241980, held by PFIZER CANADA ULC, supplied as SOLUTION for INTRAMUSCULAR ; SUBCUTANEOUS ; INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 08-Jul-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02241980 |
|---|---|
| Brand name | NEO-SYNEPHRINE |
| Generic / active ingredient | PHENYLEPHRINE HYDROCHLORIDE : 10 MG |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 10 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAMUSCULAR ; SUBCUTANEOUS ; INTRAVENOUS |
| Schedule | Ethical |
| ATC code | C01CA06 PHENYLEPHRINE |
| AHFS class | 12:12.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 08-Jul-2021 |
| Original market date | 2002-11-01 00:00:00 |
Is PHENYLEPHRINE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by OMEGA LABORATORIES LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code C01CA06 PHENYLEPHRINE. 5 of 15 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PHENYLEPHRINE HYDROCHLORIDE INJECTION | 50 MCG | SOLUTION | LABORATOIRE AGUETTANT | MARKETED | DIN 02454599 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10 MG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED | DIN 01953583 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10 MG | SOLUTION | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02477254 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1% | 10 MG / 1 ML | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02238400 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1% | 10 MG / 1 ML | SOLUTION | MONT-PHARMA INC | MARKETED | DIN 02479281 |
| NEO-SYNEPHRINE INJ LIQ 10MG/ML | 10 MG | LIQUID | STERLING WINTHROP INC. | CANCELLED POST MARKET | DIN 01928546 |
| NEO-SYNEPHRINE LIQ 1% | 1 % | LIQUID | SANOFI CANADA, INC. | CANCELLED POST MARKET | DIN 02017725 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION | 0.1 MG | SOLUTION | ACALA PHARMACEUTICALS INC. (A DIVISION OF FERNBANK MANAGEMENT CORPORATION) | CANCELLED (UNRETURNED ANNUAL) | DIN 02524686 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION | 10 MG | SOLUTION | ACALA PHARMACEUTICALS INC. (A DIVISION OF FERNBANK MANAGEMENT CORPORATION) | CANCELLED (UNRETURNED ANNUAL) | DIN 02524694 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10 MG | SOLUTION | JAMP PHARMA CORPORATION | APPROVED | DIN 02547627 |
Who else supplies PHENYLEPHRINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PHENYLEPHRINE appears in 51 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.